22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › Arcturus Therapeutics Holdings Inc. › 2024-2025

Arcturus Therapeutics Holdings Inc. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 11Ballot items
  • 176Asset managers, any item
  • 2,033Fund votes
  • June 6, 2025Meeting date

Results at a glance

Meeting of June 6, 2025: 11 items on Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 6, 2025: 9 elected · 2 approved.

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Arcturus Therapeutics Holdings Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Arcturus Therapeutics Holdings Inc.

These tallies are Arcturus Therapeutics Holdings Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Arcturus Therapeutics Holdings Inc. — official shareholder meeting results, meeting held June 6, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Dr. Peter Farrell 18,907,661---- 215,2012,883,662 99%Elected—
Elect Director: Joseph E. Payne 18,932,228---- 190,6342,883,662 99.0%Elected—
Elect Director: Andy Sassine 18,757,976---- 364,8862,883,662 98%Elected—
Elect Director: James Barlow 18,821,935---- 300,9272,883,662 98%Elected—
Elect Director: Dr. Edward W. Holmes 18,555,174---- 567,6882,883,662 97%Elected—
Elect Director: Dr. Magda Marquet 18,791,599---- 331,2632,883,662 98%Elected—
Elect Director: Dr. Jing L. Marantz 18,805,219---- 317,6432,883,662 98%Elected—
Elect Director: Dr. John H. Markels 18,969,935---- 152,9272,883,662 99.2%Elected—
Elect Director: Dr. Moncef Slaoui 19,059,965---- 62,8972,883,662 99.7%Elected—
Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement 18,472,131586,00664,724 --2,883,662 97%Approved—
Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2025, as provided in Proposal Number 3 of the Proxy Statement 21,971,16830,5894,767 ---- 99.9%Approved—

Source: Arcturus Therapeutics Holdings Inc., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.

How asset managers voted at the Arcturus Therapeutics Holdings Inc. 2024-2025 meeting

176 asset managers disclosed a vote on at least one Arcturus Therapeutics Holdings Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Andy Sassine

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 18,757,976WITHHELD: 364,886

Prior year: 98.7% for (June 14, 2024 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy Sassine

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Andy Sassine”): 18,757,976 for, 364,886 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,772,850 for, 29,880 withheld, 257 abstained.

FOR
FOR: 10,772,850ABSTAIN: 257WITHHOLD: 29,880
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,4240 0432For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X00 013,474Withhold
AIG/SunAmerica12,4140 00For
WisdomTree00 012,391Withhold
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: Dr. Edward W. Holmes

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 18,555,174WITHHELD: 567,688

Prior year: 94.7% for (June 14, 2024 meeting) ▲ 2.3 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Edward W. Holmes”): 18,555,174 for, 567,688 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,667,200 for, 135,530 withheld, 257 abstained.

FOR
FOR: 10,667,200ABSTAIN: 257WITHHOLD: 135,530
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable40,3140 022,800Mixed
MFS00 060,129Withhold
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust00 016,716Withhold
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X00 013,474Withhold
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle00 011,775Withhold

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: Dr. Jing L. Marantz

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 18,805,219WITHHELD: 317,643

Prior year: 97.1% for (June 14, 2024 meeting) ▲ 1.3 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Jing L. Marantz”): 18,805,219 for, 317,643 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,746,209 for, 56,335 withheld, 443 abstained.

FOR
FOR: 10,746,209ABSTAIN: 443WITHHOLD: 56,335
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity333,7370 056,237Mixed
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: Dr. John H. Markels

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 18,969,935WITHHELD: 152,927

Prior year: 98.7% for (June 14, 2024 meeting) ▲ 0.5 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. John H. Markels”): 18,969,935 for, 152,927 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,780,187 for, 22,800 withheld.

FOR
FOR: 10,780,187WITHHOLD: 22,800
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable40,3140 022,800Mixed
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: Dr. Magda Marquet

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 18,791,599WITHHELD: 331,263

Prior year: 97.2% for (June 14, 2024 meeting) ▲ 1.1 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Magda Marquet”): 18,791,599 for, 331,263 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,746,209 for, 56,335 withheld, 443 abstained.

FOR
FOR: 10,746,209ABSTAIN: 443WITHHOLD: 56,335
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity333,7370 056,237Mixed
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: Dr. Moncef Slaoui

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 19,059,965WITHHELD: 62,897
Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Moncef Slaoui”): 19,059,965 for, 62,897 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,802,987 for.

FOR
FOR: 10,802,987
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: Dr. Peter Farrell

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 18,907,661WITHHELD: 215,201

Prior year: 99.2% for (June 14, 2024 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Peter Farrell”): 18,907,661 for, 215,201 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,800,670 for, 2,317 withheld.

FOR
FOR: 10,800,670WITHHOLD: 2,317
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: James Barlow

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 18,821,935WITHHELD: 300,927

Prior year: 97.4% for (June 14, 2024 meeting) ▲ 1.1 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: James Barlow”): 18,821,935 for, 300,927 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,723,409 for, 79,135 withheld, 443 abstained.

FOR
FOR: 10,723,409ABSTAIN: 443WITHHOLD: 79,135
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity333,7370 056,237Mixed
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable40,3140 022,800Mixed
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Elect Director: Joseph E. Payne

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 18,932,228WITHHELD: 190,634

Prior year: 99.6% for (June 14, 2024 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Joseph E. Payne”): 18,932,228 for, 190,634 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 18,907,661 | 215,201 | 2,883,662 (2) Joseph E. Payne | 18,932,228 | 190,634 | 2,883,662 (3) Andy Sassine | 18,757,976 | 364,886 | 2,883…”
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 10,802,987 for.

FOR
FOR: 10,802,987
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).

Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 18,472,131AGAINST: 586,006

Prior year: 94.9% for (June 14, 2024 meeting) ▲ 2.0 pts

Details: description as filed, official tally, votes by 176 asset managers

Description as filed by funds: Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement”): 18,472,131 for, 586,006 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal was approved.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 53 asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity333,73756,237 00Mixed
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS060,129 00Against
State Street59,67920 00For
TIAA54,7920 00For
American Century053,003 00Against
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Investment Managers Series Trust II18,3220 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For

Fund voting reports, all 53 managers: 10,642,539 for, 178,770 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 141 asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
Nikko Asset Management Co., Ltd.1,927,1050 00For
BlackRock640,7183,271 00For
State Street363,6927,790 00For
Woodline Partners LP366,7900 00For
JUPITER ASSET MANAGEMENT LTD361,0800 00For
GEODE CAPITAL MANAGEMENT, LLC334,2190 00For
Vestal Point Capital, LP273,4670 00For
JPMorgan224,0670 00For
Charles Schwab195,9090 00For
Northern Trust130,512117 00For
JACOBS LEVY EQUITY MANAGEMENT, INC115,0590 00For
NORDEA INVESTMENT MANAGEMENT AB094,419 00Against
STATE OF WISCONSIN INVESTMENT BOARD80,1790 00For
Wellington67,5670 00For
Goldman Sachs62,4370 00For
Vanguard60,8680 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/060,129 00Against
Fidelity057,455 00Against
Nuveen55,9250 00For
American Century053,315 00Against
BALYASNY ASSET MANAGEMENT L.P.42,8390 00For
Dimensional42,7070 00For
MELLON INVESTMENTS Corp35,5770 00For
Putnam34,3700 00For

Institutional-manager reports, all 141 managers: 10,437,184 for, 369,917 against. Showing the 25 largest; every one is in the interactive database (link above).

Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting…

Official resultAUDIT-RELATEDReported outcome: Approved

99.9% Approved · of votes cast

FOR 99.9%
FOR: 21,971,168AGAINST: 30,589

Prior year: 99.9% for (June 14, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2025, as provided in Proposal Number 3 of the Proxy Statement”): 21,971,168 for, 30,589 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2025, as provided in Proposal Number 3 of the Proxy Statement”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 10,821,309 for.

FOR
FOR: 10,821,309
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Investment Managers Series Trust II18,3220 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
AIG/SunAmerica12,4140 00For
WisdomTree12,3910 00For

Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).

Largest Arcturus Therapeutics Holdings Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 27,000,000 shares outstanding at the time of that meeting.

Fund voting reports: top Arcturus Therapeutics Holdings Inc. shareholders by shares voted on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named…”, 2024-2025
#Asset manager % of shares outstanding
1Federated Hermes 17.39%
2ARK ETF Trust 7.30%
3Vanguard 6.31%
4BlackRock 3.78%
5Fidelity 1.44%
6Charles Schwab 0.73%
7Dimensional 0.51%
8Goldman Sachs 0.28%
9Equitable 0.23%
10MFS 0.22%
Institutional-manager reports: top Arcturus Therapeutics Holdings Inc. shareholders by shares voted on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named…”, 2024-2025
#Asset manager % of shares outstanding
1Federated Hermes 17.39%
2Nikko Asset Management Co., Ltd. 7.14%
3BlackRock 2.39%
4State Street 1.38%
5Woodline Partners LP 1.36%
6JUPITER ASSET MANAGEMENT LTD 1.34%
7GEODE CAPITAL MANAGEMENT, LLC 1.24%
8Vestal Point Capital, LP 1.01%
9JPMorgan 0.83%
10Charles Schwab 0.73%

Reported Arcturus Therapeutics Holdings Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Arcturus Therapeutics Holdings Inc. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Federated Hermes, Inc.3,303,640 12.24%Schedule 13G, filed January 8, 2026
ARK Investment Management LLC2,947,556 10.92%Schedule 13G, filed May 7, 2026
BlackRock2,759,970 10.22%Form 13F, quarter ended March 31, 2025
Amova Asset Management Americas, Inc.1,947,835 7.21%Schedule 13G, filed November 13, 2025
Vanguard Group1,748,928 6.48%Form 13F, quarter ended March 31, 2025
State Street1,280,451 4.74%Form 13F, quarter ended March 31, 2025
Dimensional Fund Advisors616,634 2.28%Form 13F, quarter ended March 31, 2025
Geode Capital569,620 2.11%Form 13F, quarter ended March 31, 2025
Morgan Stanley551,726 2.04%Form 13F, quarter ended March 31, 2025
Goldman Sachs509,712 1.89%Form 13F, quarter ended March 31, 2025

Percentages above are of 27,000,000 shares outstanding, as reported by Arcturus Therapeutics Holdings Inc. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Arcturus Therapeutics Holdings Inc.'s shareholder meeting held June 6, 2025, in the 2024-2025 proxy season, 176 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 2,033 separate fund positions. On the most widely held item on that ballot — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — Arcturus Therapeutics Holdings Inc.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Arcturus Therapeutics Holdings Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Arcturus Therapeutics Holdings Inc.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Arcturus Therapeutics Holdings Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “Arcturus Therapeutics Holdings (ARCT) 2025 Annual Meeting”, https://proxyvotesnow.com/company/arcturus-therapeutics-holdings-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.